Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
4.45M
-
Shares change
-
+38K
-
Total reported value, excl. options
-
$9.87M
-
Value change
-
+$84K
-
Number of buys
-
1
-
Price
-
$2.21
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q4 2023
3 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q4 2023.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.45M shares
of 374M outstanding shares and own 1.19% of the company stock.
Largest 10 shareholders include Indaba Capital Management, L.P. (7.45M shares), Caligan Partners LP (7.04M shares), NEUBERGER BERMAN GROUP LLC (4.37M shares), VANGUARD GROUP INC (4.13M shares), MORGAN STANLEY (3.93M shares), PRIMECAP MANAGEMENT CO/CA/ (3.05M shares), BALYASNY ASSET MANAGEMENT L.P. (2.18M shares), Hollow Brook Wealth Management LLC (1.87M shares), BlackRock Inc. (1.61M shares), and MILLENNIUM MANAGEMENT LLC (1.48M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.